Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TRUSOPT ELVIUM LIFE SCIENCES Resolved 2% Updated Report 2025-03-22 252634
TIMOPTIC-XE ELVIUM LIFE SCIENCES Resolved 0.5% Updated Report 2025-03-22 252828
LISINOPRIL SIVEM PHARMACEUTICALS ULC Actual shortage 5MG Updated Report 2025-03-22 250137
GENOTROPIN PFIZER CANADA ULC Resolved 1.6MG Updated Report 2025-03-22 201511
CLARITHROMYCIN SIVEM PHARMACEUTICALS ULC Actual shortage 250MG Updated Report 2025-03-22 250134
COSOPT ELVIUM LIFE SCIENCES Resolved 5MG 20MG Updated Report 2025-03-22 253012
ACH-LEVETIRACETAM ACCORD HEALTHCARE INC Actual shortage 250MG Updated Report 2025-03-22 253221
VENTOLIN DISKUS GLAXOSMITHKLINE INC Anticipated shortage 200MCG Updated Report 2025-03-21 252627
IMITREX GLAXOSMITHKLINE INC Resolved 20MG Updated Report 2025-03-21 252843
APO-GABAPENTIN APOTEX INC Resolved 400MG Updated Report 2025-03-21 250930

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TEVA-FINGOLIMOD TEVA CANADA LIMITED Discontinued 0.5MG New Report 2025-03-20 253186
TEVA-PAROXETINE TEVA CANADA LIMITED Discontinued 10MG New Report 2025-03-20 253182
TEVA-PRAVASTATIN TEVA CANADA LIMITED Discontinued 40MG New Report 2025-03-20 253177
TEVA-PRAVASTATIN TEVA CANADA LIMITED Discontinued 20MG New Report 2025-03-20 253174
TEVA-PRAVASTATIN TEVA CANADA LIMITED Discontinued 10MG New Report 2025-03-20 253171